In the past decade, biopharma companies have considerably transformed not just the science of drug discovery, but the way they conduct their research. They’re increasingly supplementing their internal research by outsourcing and collaborating with external research suppliers. This dramatic shift towards externalization is an attempt to make the R&D process more efficient and cost effective, thereby allowing researchers to make greater use of their limitless potential.
We at scientist.com support this change in the R&D landscape by proactively identifying and providing access to new research suppliers and innovations through our Uber-like platform for scientific services. This month, we have added a staggering amount of new specialized CROs and innovative listings. Take a look at our monthly Top 8 Innovation Picks:
